Community-Acquired Pneumonia with Dr. Anna Thorner

Published

Community-acquired pneumonia is one of the most commonly encountered infections in the hospital setting. In this interview, Dr. Anna Thorner discusses the basics of diagnosing and treating pneumonia as well as delving into the roles of procalcitonin and glucocorticoids in its management.

00:00 introduction
03:03 a case and differential diagnosis
06:05 procalcitonin
10:16 a second case and first line inpatient treatments
14:04 causative pathogens
18:22 testing for a causative pathogen
23:18 “healthcare-associated pneumonia” and drug-resistance
29:39 MRSA and Pseudomonas
34:46 duration and de-escalation of therapy
36:48 glucocorticoids for pneumonia
40:32 summary and concluding remarks
45:13 credits

This podcast is part of the series, Curbside Consults, which complements the foundational information in Rotation Prep by taking a deep dive into key topics with expert clinicians and educators. As we explore the details of pathophysiology and critique the evidence behind clinical practice, these conversations are intended to give you better understanding of the topic and greater confidence when treating your patients.

Dr. Thorner is an Associate Physician in the Division of Infectious Diseases at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Assistant Professor at Harvard Medical School, and Deputy Editor of Infectious Diseases and Co-Director of Editorial Projects at UpToDate/Wolters Kluwer Health.

Mike Mi is a 2017-2018 NEJM Editorial Fellow and a hospitalist at Beth Israel Deaconess Medical Center. He graduated from Harvard Medical School and completed his internal medicine training at BIDMC.